Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo

Xianrong Zhang1, Joseph Tamasi, Xin Lu

  • 1Department of Orthopaedic Surgery, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Insights

The epidermal growth factor receptor (EGFR) signaling pathway is crucial for bone health, promoting bone formation and regulating bone mass. Inhibiting EGFR reduces bone mass, while activating it increases bone density.

Area of Science:

  • Bone biology
  • Cell signaling
  • Skeletal system development

Background:

  • The epidermal growth factor receptor (EGFR) signaling pathway is essential in many biological processes but its role in skeletal homeostasis is unclear.
  • Understanding EGFR's function in bone development and maintenance is critical for addressing bone diseases.

Purpose of the Study:

  • To investigate the in vivo role of EGFR in skeletal development and homeostasis.
  • To determine the specific contribution of EGFR signaling to bone metabolism and microarchitecture.

Main Methods:

  • Generated transgenic mouse models with altered EGFR activity (knockout, dominant-negative, and constitutively active alleles).
  • Utilized peripheral quantitative computed tomography (pQCT) and micro-computed tomography (µCT) for bone phenotyping.
  • Conducted histomorphometry and colony-forming unit-fibroblast (CFU-F) assays to assess cellular and microarchitectural changes.
  • Administered EGFR inhibitors to wild-type mice to evaluate pharmacologic effects.

Main Results:

  • Reduced EGFR activity in osteoblasts led to decreased trabecular bone mass, altered microarchitecture, reduced osteoblast numbers, and increased osteoclast numbers.
  • EGFR inhibition in wild-type mice significantly reduced trabecular bone volume.
  • Mice with constitutively active EGFR showed increased trabecular and cortical bone.
  • Bone marrow mesenchymal stem cell populations were reduced with diminished EGFR activity.

Conclusions:

  • EGFR signaling is a critical regulator of bone metabolism, primarily exerting an anabolic effect.
  • Targeting EGFR signaling represents a potential therapeutic strategy for modulating bone mass and treating skeletal disorders.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...